Cargando…

Assessing the Safety of COVID-19 Vaccines: A Primer

Vaccines against COVID-19 are being developed at speeds not previously achieved. With this unprecedented effort comes challenges for post-marketing safety monitoring and challenges for vaccine safety communication. To deploy these new vaccines fast across diverse populations, it is vital that robust...

Descripción completa

Detalles Bibliográficos
Autor principal:	Petousis-Harris, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526515/ https://www.ncbi.nlm.nih.gov/pubmed/32997318 http://dx.doi.org/10.1007/s40264-020-01002-6

Ejemplares similares

Correction to: Assessing the Safety of COVID-19 Vaccines: A Primer
por: Petousis-Harris, Helen
Publicado: (2021)

Pharmacy Compounding Primer for Physicians: Prescriber Beware
por: Sellers, Sarah, et al.
Publicado: (2012)

A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment
por: Sullivan, Tim, et al.
Publicado: (2022)

Safety of International Professional Sports Competitions During the COVID-19 Pandemic: The Association Football Experience
por: Caniza, Horacio, et al.
Publicado: (2022)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials
por: Patera, Andriani C., et al.
Publicado: (2023)

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
por: Jacobson, Sheldon H., et al.
Publicado: (2021)

Novel Strategies for the Treatment of COVID-19
por: McCarthy, Matthew W.
Publicado: (2022)

Artificial Intelligence and the Future of the Drug Safety Professional
por: Danysz, Karolina, et al.
Publicado: (2018)

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
por: Atal, Shubham, et al.
Publicado: (2020)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Implementing a mandatory COVID-19 vaccine: ethical challenges
por: Arora, A
Publicado: (2022)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
por: Atal, Shubham, et al.
Publicado: (2020)

Optimizing the trauma resuscitation bay during the covid-19 pandemic
por: Livingston, David Hugh, et al.
Publicado: (2020)

Resuming elective surgical services in times of COVID-19 infection
por: Coimbra, Raul, et al.
Publicado: (2020)

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
por: Rajasimhan, Suraj, et al.
Publicado: (2020)

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
por: Cadogan, Cathal A., et al.
Publicado: (2015)

Black Swan Events and Intelligent Automation for Routine Safety Surveillance
por: Kjoersvik, Oeystein, et al.
Publicado: (2022)

Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
por: Bianconi, Vanessa, et al.
Publicado: (2020)

Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview
por: Parreiras Martins, Maria Auxiliadora, et al.
Publicado: (2020)

Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
por: Kow, Chia Siang, et al.
Publicado: (2020)

The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19
por: Panera, Nadia, et al.
Publicado: (2020)

Paradigm shift of drug information centers during the COVID-19 pandemic
por: Khatiwada, Asmita Priyadarshini, et al.
Publicado: (2020)

Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
por: Khan, Sikandar Hayat, et al.
Publicado: (2020)

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
por: Torres, Tiago, et al.
Publicado: (2020)

Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic
por: Shurlock, Jonathan, et al.
Publicado: (2021)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020)

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
por: Hum, Christine, et al.
Publicado: (2021)

The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
por: Smith, Meredith Y., et al.
Publicado: (2016)

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic
por: Kemp, Michael T, et al.
Publicado: (2020)

The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
por: Casucci, Gerardo, et al.
Publicado: (2020)

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ns90560rudlvai0p927991nhd